What Researchers Did
The author wrote a review of what is known about long COVID brain fog and postural orthostatic tachycardia syndrome (POTS), including their possible causes and treatments.
What They Found
This narrative review of long COVID nervous system complications reports that brain fog and POTS strongly affect quality of life and ability to return to work, and that the cause is unknown but likely has many parts. The abstract names immune dysregulation and small blood vessel problems as playing central roles. It reports that brain fog affects 10% to 88% of people after COVID-19, depending on the virus variant and whether the person was hospitalized, while the rate of long COVID POTS is unknown. Treatment is mostly supportive. The abstract says marginal benefits were found with cognitive behavioural therapy, hyperbaric oxygen therapy, and supplements for brain fog. Prospective studies showed that some patients still had symptoms and nerve-related deficits a year after infection.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
The abstract describes a review of other work, not a new trial, and it gives no HBOT protocol or study details, so the marginal benefit it mentions cannot be judged from the abstract alone.